Open Opportunities

NIH Research Evaluation and Commercialization Hubs (REACH) Awards (U01 Clinical Trial Not Allowed)
RFA-OD-19-014 · Posted Date: 12/17/2018

HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Epidemic (R41/R42 - Clinical Trial Optional)
RFA-DA-19-020 · Posted Date: 12/10/2018

HEAL Initiative: Translational Devices to Treat Pain (U44 Clinical Trial Optional)
RFA-NS-19-017 · Posted Date: 12/10/2018

HEAL Initiative: Pain Management Effectiveness Research Network: Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
RFA-NS-19-021 · Posted Date: 12/10/2018

HEAL Initiative: Pragmatic and Implementation Studies for the Management of Pain to Reduce Opioid Prescribing (PRISM) (UG3/UH3, Clinical Trials Optional)
RFA-AT-19-004 · Posted Date: 12/10/2018

HEAL Initiative: Translational Development of Devices to Treat Pain (U18 Clinical Trial Not Allowed)
RFA-EB-18-003 · Posted Date: 12/10/2018

Discovery of Biomarkers, Biomarker Signatures, and Endpoints for Pain (R61/R33 Clinical Trial Optional)
RFA-NS-18-041 · Posted Date: 08/02/2018

Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative Innovation Award, (U01 Clinical Trial Optional)
PAR-19-099 · Posted Date: 12/12/2018

Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R43/R44 Clinical Trial Not Allowed)
PA-19-034 · Posted Date: 10/24/2018

Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed)
PA-19-029 · Posted Date: 10/17/2018

Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed)
PAR-18-952 · Posted Date: 10/04/2018

Limited Competition for NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (U01 Clinical Trial Required)
PAR-18-910 · Posted Date: 08/31/2018

Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
PA-18-906 · Posted Date: 08/22/2018

Innovative Therapies and Tools for Screenable Disorders (R01 Clinical Trial Optional)
PAR-18-689 · Posted Date: 03/01/2018

Innovative Therapies and Tools for Screenable Disorders (R03 Clinical Trial Optional)
PAR-18-690 · Posted Date: 03/01/2018

Clinical Trial Planning: Therapeutic/Indication Pairing Strategies (U34) (Clinical Trials Not Allowed)
PAR-18-462 · Posted Date: 11/30/2017

Bench Testing Therapeutic/Indication Pairing Strategies (UG3/UH3)
PAR-17-465 · Posted Date: 08/21/2017

Development of Highly Innovative Tools and Technology for Analysis of Single Cells (STTR) (R41/R42)
PA-17-148 · Posted Date: 02/01/2017

Platform Delivery Technologies for Nucleic Acid Therapeutics (R43/R44)
PAR-17-035 · Posted Date: 10/27/2016

Limited Competition: Administrative Supplements to Enhance Network Capacity: Collaborative Opportunities for the CTSA Program (Admin Supp)
PA-16-328 · Posted Date: 06/14/2016

Successor-in-Interest (Type 6 Parent) (PA-16-286)
PA-16-286 · Posted Date: 05/25/2016

Research Supplements to Promote Diversity in Health-Related Research (Admin Supp) (PA-16-288)
PA-16-288 · Posted Date: 05/25/2016

Change of Grantee Organization (Type 7 Parent) (PA-16-285)
PA-16-285 · Posted Date: 05/25/2016

NIH Implementation of the Final Rule on the Federal Policy for the Protection of Human Subjects (Common Rule)
NOT-OD-19-050 · Posted Date: 01/02/2019

HEAL Initiative: Announcement of the NCATS ASPIRE Design Challenges to Develop Innovative and Catalytic Approaches Towards Solving the Opioid Crisis
NOT-TR-18-031 · Posted Date: 12/10/2018

Notice of Intent to Publish Funding Opportunity Announcements for Research to Develop, Demonstrate, and Validate Experimental Human Tissue Models that Do Not Rely on Human Fetal Tissue
NOT-OD-19-042 · Posted Date: 12/10/2018

Ruth L. Kirschstein National Research Service Award (NRSA) Stipends, Tuition/Fees and Other Budgetary Levels Effective for Fiscal Year 2019
NOT-OD-19-036 · Posted Date: 11/27/2018

Notice of Legislative Mandates in Effect for FY 2019
NOT-OD-19-030 · Posted Date: 11/09/2018

Harassment and Discrimination Protections in NIH Training Applications
NOT-OD-19-029 · Posted Date: 11/07/2018

Notice of Change to PAR-18-953 Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
NOT-TR-19-012 · Posted Date: 10/29/2018

Revised Process for SBIR/STTR Life Cycle Certifications
NOT-OD-19-025 · Posted Date: 10/29/2018

Publication of the Revised NIH Grants Policy Statement (Rev. October 2018) for FY 2019
NOT-OD-19-021 · Posted Date: 10/23/2018

Reinstatement of NIH SBIR Direct-to-Phase II Authority and Associated Updates to NCATS Platform Delivery Technologies for Nucleic Acid Therapeutics (R43/R44) Funding Opportunity Announcement
NOT-TR-19-004 · Posted Date: 10/15/2018

Notice of Change to Activity Codes allowed for Administrative Supplements to Promote Diversity in Research and Development Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed) PA-18-837
NOT-OD-19-016 · Posted Date: 10/12/2018

Review of the Accuracy of Grants Information for Fiscal Year 2018
NOT-OD-18-234 · Posted Date: 09/24/2018

NIH & AHRQ Announce Upcoming Updates to Application Instructions and Review Criteria for Research Grant Applications
NOT-OD-18-228 · Posted Date: 09/14/2018

NIH & AHRQ Announce Upcoming Updates to Application Instructions and Review Criteria for Fellowship Award Applications
NOT-OD-18-227 · Posted Date: 09/14/2018

Notice of Correction to application forms package for PA-17-326 "Administrative Supplements for the U.S.-Japan Brain Research Cooperative Program (BRCP) - U.S. Entity (Admin Supplement)"
NOT-NS-18-093 · Posted Date: 09/11/2018

Notice of the Publication of an NIH Proposal to Amend the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules to Streamline Oversight of Human Gene Transfer Protocols
NOT-OD-18-218 · Posted Date: 08/16/2018

NIH Offers Assistance to Phase II HHS SBIR and STTR Awardees through the NIH Commercialization Accelerator Program (CAP) 2018-2019
NOT-OD-18-213 · Posted Date: 07/26/2018

HHS Small Business Innovation Research (SBIR) Program Contract Solicitation (PHS 2019-1) Now Available
NOT-OD-18-209 · Posted Date: 07/18/2018

Notice of Availability of Administrative Supplements for NIH Grants that are NOT Focused on Down Syndrome to Address Specific Down Syndrome Research Objectives
NOT-OD-18-194 · Posted Date: 06/20/2018

National Center for Advancing Translational Sciences (NCATS) Policy for Support of Phase III Clinical Trial Activities for a Rare Disease or Condition
NOT-TR-18-025 · Posted Date: 05/09/2018

Notice of Change to Application Due Date to PAR-18-244 "Collaborative Innovation Award, Clinical and Translational Science Award (CTSA) Program (U01)"
NOT-TR-18-023 · Posted Date: 04/23/2018

Notice of Availability of Administrative Supplements for the NCATS Clinical and Translational Science Awards (CTSA) Program
NOT-TR-18-022 · Posted Date: 04/20/2018

Notice of NCATS Participation in PA-18-592 "Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed)"
NOT-TR-18-018 · Posted Date: 02/08/2018

Notice of Change in Bench Testing Therapeutic/Indication Pairing Strategies (UG3/UH3) (PAR-17-465)
NOT-TR-18-016 · Posted Date: 01/16/2018

Notice of Modifications for PAR-18-244 "Collaborative Innovation Award, Clinical and Translational Science Award (CTSA) Program (U01 Clinical Trial Optional)"
NOT-TR-18-013 · Posted Date: 01/16/2018

Notice of Intent to Publish a Funding Opportunity Announcement to Support New Applications in Regenerative Medicine Innovation Projects (RMIP) (UT1/UT2 - Clinical Trial Required)
NOT-HL-18-575 · Posted Date: 01/12/2018

Notice of Intent to Publish a Funding Opportunity Announcement to Support New Applications in Regenerative Medicine Innovation Projects (RMIP) (UT1/UT2 - Clinical Trial Not Allowed)
NOT-HL-18-576 · Posted Date: 01/12/2018

Notice of Intent to Publish a Funding Opportunity Announcement to Support New Applications in Regenerative Medicine Innovation Projects (RMIP) (U43/U44 - Clinical Trial Required)
NOT-HL-18-577 · Posted Date: 01/12/2018

Revision: NIH Policy and Guidelines on the Inclusion of Individuals Across the Lifespan as Participants in Research Involving Human Subjects
NOT-OD-18-116 · Posted Date: 12/19/2017

Changes to FOA RFA-TR-17-001 "Pre-application for the NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (X02)"
NOT- TR-17-015 · Posted Date: 04/07/2017